Completed PHASE2 INTERVENTIONAL 2-arm NCT02404337

Betaine METABOLISM OF PATIENTS With Homocystinuria (HCTBETAINE)

Sponsor: Assistance Publique - Hôpitaux de Paris

Interventions Betaine

Updated 7 times since 2017 Last updated: Feb 1, 2023 Started: Jul 31, 2015 Primary completion: Dec 31, 2017 Completion: Feb 28, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02404337, this PHASE2 trial focuses on Homocystinuria and remains completed. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Mar 2023 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Mar 2023 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Mar 2018 — Jun 2018 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2017 — Mar 2018 [monthly]

Recruiting PHASE2

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assistance Publique - Hôpitaux de Paris

Data source: Assistance Publique - Hôpitaux de Paris

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Paris, France